View all news

Nevro to Announce Preliminary Second Quarter Worldwide Revenue, Discuss Full Year 2018 Revenue Guidance and Provide Business Updates

July 13, 2018
Company to Host Conference Call on Monday, July 16, 2018 at 5:30 a.m. PT / 8:30 a.m. ET

REDWOOD CITY, Calif., July 13, 2018 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that its management will be hosting a business update conference call before market open beginning at 5:30 a.m. Pacific Time (8:30 a.m. Eastern Time) on Monday, July 16, 2018. 

Investors interested in listening to the conference call may do so by dialing (866) 393-4306 for U.S. callers or (734) 385-2616 for international callers (Conference ID: 2196519), or logging into the webcast on the "Investors" section of the Company's website at www.nevro.com/investors. Following the call, a replay will be available on the Investor Events and Presentations webpage of the Company's website.

About Nevro

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Senza® system and Senza II™ system are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.

Investor Relations Contact:
Nevro Investor Relations
(650) 433-3247
ir@nevro.com

.

 

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/nevro-to-announce-preliminary-second-quarter-worldwide-revenue-discuss-full-year-2018-revenue-guidance-and-provide-business-updates-300680880.html

SOURCE Nevro Corp.

Multimedia Files:

View all news